Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell

Toxicology Letters

Volumn 187, Issue 2, 2009, Pages 69-76

  Huang, Zhi ^a,b   Li, Jun ^c   Zhang, Sichun ^a   Zhang, Xinrong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b JINAN UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic; Embryonic stem (ES) cell; Reactive oxygen species (ROS); Selenium; Selenoprotein

Indexed keywords

ANTIOXIDANT; ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SELENOPROTEIN; SELENOPROTEIN GPX1; SELENOPROTEIN GPX4; SELENOPROTEIN H; SELENOPROTEIN TR1; SODIUM SELENITE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN CGR8; CULTURE MEDIUM; DETOXIFICATION; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE; IMMUNOBLOTTING; MODULATION; MOLECULAR INTERACTION; MOUSE; MOUSE EMBRYO; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RODENT; UPREGULATION;

ANIMALS; APOPTOSIS; ARSENATES; ARSENITES; CELL GROWTH PROCESSES; CELL LINE; CELL NUCLEUS; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; MICE; NF-E2-RELATED FACTOR 2; OCTAMER TRANSCRIPTION FACTOR-3; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELENOPROTEINS; SODIUM SELENITE;

RODENTIA;

EID: 63249134666     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.01.024     Document Type: Article

References (64)

1. Ahuja Y.R., Vijayalakshmi V., and Polasa K. Stem cell test: a practical tool in toxicogenomics. Toxicology 231 (2007) 1-10
2. Andrew A.S., Jewell D.A., Mason R.A., Whitfield M.L., Moore J.H., and Karagas M.R. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. Population. Environ. Health Perspect. 116 (2008) 524-531
3. Argos M., Kibriya M.G., Parvez F., Jasmine F., Rakibuz-Zaman M., and Ahsan H. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1367-1375
4. Banning A., Deubel S., Kluth D., Zhou Z.W., and Brigelius-Flohe R. The GI-GPx gene is a target for Nrf2. Mol. Cell Biol. 25 (2005) 4914-4923
5. Biswas S., Talukder G., and Sharma A. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat. Res. Gen. -Tox. En. 441 (1999) 155-160
6. Brigelius-Flohé R. Selenium compounds and selenoproteins in cancer. Chem. Biodivers. 5 (2008) 389-395
7. Burnichon V., Jean S., Bellon L., Maraninchi M., Bideau C., Orsière T., Margotat A., Gérolami V., Botta A., and Bergé-Lefranc J.L. Patterns of gene expressions induced by arsenic trioxide in cultured human fibroblasts. Toxicol. Lett. 143 (2003) 155-162
8. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., and Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14 (2003) 303-310
9. Chen Y., Hall M., Graziano J.H., Slavkovich V., van Geen A., Parvez F., and Ahsan H. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 207-213
10. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Park H.K., Sanders B.B., Smith C.L., and Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial-a randomized controlled trial. JAMA 276 (1996) 1957-1963
11. Curran J.E., Jowett J.B.M., Elliott K.S., Gao Y., Gluschenko K., Wang J.M., Azim D.M.A., Cai G.W., Mahaney M.C., Comuzzie A.G., Dyer T.D., Walder K.R., Zimmet P., MacCluer J.W., Collier G.R., Kissebah A.H., and Blangero J. Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37 (2005) 1234-1241
12. Dinkova-Kostova A.T., Holtzclaw W.D., and Wakabayashi N. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 44 (2005) 6889-6899
13. Driscoll D.M., and Copeland P.R. Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23 (2003) 17-40
14. Du Y.Z., Wang K.K., Fang H., Li J.M., Xiao D., Zheng P.Z., Chen Y.L., Fan H.Y., Pan X.L., Zhao C.J., Zhang Q.H., Imbeaud S., Graudens E., Eveno E., Auffray C., Chen S.J., Chen Z., and Zhang J. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood 107 (2006) 1582-1590
15. Ebert R., Ulmer M., Zeck S., Meissner-Weigl J., Schneider D., Stopper H., Schupp N., Kassem M., and Jakob F. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells 24 (2006) 1226-1235
16. Gailer J., George G.N., Pickering I.J., Prince R.C., Ringwald S.C., Pemberton J.E., Glass R.S., Younis H.S., DeYoung D.W., and Aposhian H.V. A metabolic link between arsenite and selenite: the seleno-bis(S-glutathionyl) arsinium ion. JACS 122 (2000) 4637-4639
17. Ganyc D., Talbot S., Konate F., Jackson S., Schanen B., Cullen W., and Self W.T. Impact of trivalent arsenicals on selenoprotein synthesis. Environ. Health Perspect. 115 (2007) 346-353
18. Gregus Z., Gyurasics A., and Koszorus L. Interactions between selenium and group Va-metalloids (arsenic, antimony and bismuth) in the biliary excretion. Environ. Toxicol. Pharmacol. 5 (1998) 89-99
19. Gromer S., Eubel J.K., Lee B.L., and Jacob J. Human selenoproteins at a glance. Cell. Mol. Life Sci. 62 (2005) 2414-2437
20. 2+ mobilization and neuroendocrine secretion. FASEB J. 2 (2008) 1756-1768
21. Hamadeh H.K., Trouba K.J., Amin R.P., Afshari C.A., and Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol. Sci. 69 (2002) 306-316
22. Hei T.K., Liu S.X., and Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8103-8107
23. Hoffmann P.R., Hoge S.C., Li P.A., Hoffmann F.W., Hashimoto A.C., and Berry M.J. The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res. 35 (2007) 3963-3973
24. Holmgren A., and Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. (1995) 199-208
25. Huang Z., Pei Q., Sun G., Zhang S., Liang J., Gao Y., and Zhang X. Low selenium status affects arsenic metabolites in an arsenic exposed population with skin lesions. Clin. Chim. Acta 387 (2008) 139-144
26. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133 (2002) 1-16
27. IARC. Some Drinking-water Disinfectants and Contaminants, including Arsenic, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2004), IARC Press, Lyon p. 512
28. Kibriya M.G., Jasmine F., Argos M., Verret W.J., Rakibuz-Zaman M., Ahmed A., Parvez F., and Ahsan H. Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol. Lett. 169 (2007) 162-176
29. Kitchin K.T., and Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol. Lett. 137 (2003) 3-13
30. Kobayashi M., and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46 (2006) 113-140
31. Komissarova E.V., Saha S.K., and Rossman T.G. Dead or dying: the importance of time in cytotoxicity assays using arsenite as an example. Toxicol. Appl. Pharmacol. 202 (2005) 99-107
32. Korotkov K.V., Kumaraswamy E., Zhou Y., Hatfield D.L., and Gladyshev V.N. Association between the 15-kDa selenoprotein and UDP-glucose: glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 276 (2001) 15330-15336
33. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., and Gladyshev V.N. Characterization of mammalian selenoproteomes. Science 300 (2003) 1439-1443
34. Labunskyy V.M., Hatfield D.L., and Gladyshev V.N. The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life 59 (2007) 1-5
35. Li J., Pan G.J., Cui K., Liu Y.W., Xu S.B., and Pei D.Q. A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. J. Biol. Chem. 282 (2007) 19481-19492
36. Miyazaki K., Watanabe C., Mori K., Yoshida K., and Ohtsuka R. The effects of gestational arsenic exposure and dietary selenium deficiency on selenium and selenoenzymes in maternal and fetal tissues in mice. Toxicology 208 (2005) 357-365
37. National Research Council. Arsenic in Drinking Water, Update 0-309-07629-3 (2001), National Academy Press, Washington, DC
38. Novoselov S.V., Kryukov G.V., Xu X.M., Carlson B.A., Hatfield D.L., and Gladyshev V.N. Selenoprotein H is a nucleolar thioredoxin-like protein with a unique expression pattern. J. Biol. Chem. 282 (2007) 11960-11968
39. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., and Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60 (1990) 461-472
40. Palmieri S.L., Peter W., Hess H., and Schöler H.R. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 166 (1994) 259-267
41. Panee J., Stoytcheva Z.R., Liu W., and Berry M.J. Selenoprotein H is redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification. J. Biol. Chem. 282 (2007) 23759-23765
42. Pesce M., and Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
43. Pi J.B., Qu W., Reece J.M., Kumagai Y., and Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell Res. 290 (2003) 234-245
44. Posey T., Weng T., Chen Z., Chintagari N.R., Wang P., Jin N., Stricker H., and Liu L. Arsenic-induced changes in the gene expression of lung epithelial L2 cells: implications in carcinogenesis. BMC Genomics 9 (2008) 115
45. Quinlan L.R., Faherty S., and Kane M.T. Phospholipase C and protein kinase C involvement in mouse embryonic stem-cell proliferation and apoptosis. Reproduction 126 (2003) 121-131
46. Ramadan D., Rancy P.C., Nagarkar R.P., Schneider J.P., and Thorpe C. Arsenic(III) species inhibit oxidative protein folding in vitro. Biochemistry 48 (2009) 424-432
47. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., and Melton D.A. Stemness: transcriptional profiling of embryonic and adult stem cells. Science 298 (2002) 597-600
48. Rea M.A., Gregg J.P., Qin Q., Phillips M.A., and Rice R.H. Global alteration of gene expression in human keratinocytes by inorganic arsenic. Carcinogenesis 24 (2003) 747-756
49. Rohwedel J., Guan K., Hegert C., and Wobus A.M. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. Toxicol. In Vitro 15 (2001) 741-753
50. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533 (2003) 37-65
51. Rossman T.G., and Uddin A.N. Selenium prevents spontaneous and arsenite-induced mutagenesis. Anim. Environ. 1275 (2005) 173-179
52. Sakurai A., Nishimoto M., Himeno S., Imura N., Tsujimoto M., Kunimoto M., and Hara S. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J. Cell Physiol. 203 (2005) 529-537
53. Shi H.L., Shi X.L., and Liu K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 255 (2004) 67-78
54. Socci D.J., Bjugstad K.B., Jones H.C., Pattisapu J.V., and Arendash G.W. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the h-TX rat model. Exp. Neurol. 155 (1999) 109-117
55. Styblo M., and Thomas D.J. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol. Appl. Pharmacol. 172 (2001) 52-61
56. Su P.F., Hu Y.J., Ho I.C., Cheng Y.M., and Lee T.C. Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ. Health Perspect. 114 (2006) 394-403
57. Talalay P., De Long M.J., and Prochaska H.J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 8261-8265
58. Tapio S., and Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. -Rev. Mutat. 612 (2006) 215-246
59. Uddin A.N., Burns F.J., and Rossman T.G. Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 26 (2005) 2179-2186
60. Walton F.S., Waters S.B., Jolley S.L., LeCluyse E.L., Thomas D.J., and Styblo M. Selenium compounds modulate the activity of recombinant rat As-III-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem. Res. Toxicol. 16 (2003) 261-265
61. Yang L.S., Wang W.Y., Hou S.F., Peterson P.J., and Williams W.P. Effects of selenium supplementation on arsenism: an intervention trial in Inner Mongolia. Environ. Geochem. Health 24 (2002) 359-374
62. Ye Y., Shibata Y., Yun C., Ron D., and Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429 (2004) 841-847
63. Zhu H., Itoh K., Yamamoto M., Zweier J.L., and Li Y.B. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett. 579 (2005) 3029-3036
64. Zhu H., Zhang L., Itoh K., Yamamoto M., Ross D., Trush M.A., Zweier J.L., and Li Y. Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress. Free Radic. Bio. Med. 41 (2006) 132-143